Thirty Madison IPO

Summary*

Thirty Madison, founded in 2017 and headquartered in New York, is a virtual-first healthcare company specializing in providing accessible and effective treatments for people with ongoing conditions. The company's innovative approach focuses on delivering lifetime care without the need for in-person visits, addressing a growing demand for convenient healthcare solutions.

Since its inception, Thirty Madison has demonstrated significant growth and attracted substantial investor interest. The company has raised a total of $205 million across multiple funding rounds, with its most recent Series C round in June 2021 valuing the company at $1 billion. This unicorn status highlights Thirty Madison's strong market position and potential for future expansion.

While there is currently no official information regarding Thirty Madison's IPO prospects, the company's rapid growth and substantial funding could potentially position it for consideration of going public in the future. However, it's important to note that any discussions about a potential Thirty Madison IPO remain speculative at this time.

Several factors could influence Thirty Madison's decision to pursue an IPO, including market conditions, the company's financial performance, and its long-term growth strategy. The healthcare technology sector has seen increased investor interest in recent years, which could potentially create a favorable environment for companies like Thirty Madison to consider public offerings. However, the timing and likelihood of an IPO remain uncertain without official announcements from the company.

Investors interested in the potential opportunity to invest in Thirty Madison stock should keep an eye on official company announcements and financial news sources for any updates regarding a possible IPO. As with any investment decision, it's crucial to conduct thorough research and consider the associated risks before making any financial commitments.

Get $1000 towards your
first investment 

*Terms and conditions apply. See details

Get Your Offer

How to invest in Thirty Madison

While Thirty Madison's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the digital health and telemedicine sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging healthcare innovators before they go public.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.